Kathleen Griffith, PhD, MPH, FNP-BC, AOCN© is Associate Professor of Nursing and Medicine at the George Washington University, where she also serves as the assistant dean for the PhD program in nursing.
The impact of Dr. Griffith’s work in chemotherapy-induced peripheral neuropathy (CIPN) is recognized internationally. Her primary contribution to the field is through clinical research, where she has sought to understand the natural history of CIPN through studies of the influence of type and dosing of chemotherapy on CIPN severity as well as how CIPN severity varies in the setting of concurrent symptoms. She co-invented a measure of CIPN, the TNSc©, which is now used routinely by academic scientists and industry. The impact of Dr. Griffith’s work includes ongoing research funded by the National Institutes of Health and Department of Veterans Affairs. She and her team are testing physical activity as an interventional approach to manage CIPN-related pain with an emphasis on functional and nerve fiber density changes following exercise. Her long-term research goal is to reduce the suffering associated with CIPN and related pain conditions through interventions that remain in control of the patient. She remains clinically active as an oncology-certified nurse practitioner at the George Washington University Cancer Center and manages patients with CIPN, functional impairment, and other symptoms that impact long-term health outcomes.
Dr. Griffith received her BSN and MS from Georgetown University and her MPH and PhD from the University of Maryland, Baltimore. She completed her post-doctoral research fellowship at the Johns Hopkins University.